↓ Skip to main content

Cytoprotection “gone astray’’: Nrf2 and its role in cancer

Overview of attention for article published in OncoTargets and therapy, August 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
1 X user
patent
3 patents

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
122 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cytoprotection “gone astray’’: Nrf2 and its role in cancer
Published in
OncoTargets and therapy, August 2014
DOI 10.2147/ott.s36624
Pubmed ID
Authors

Claudia Geismann, Alexander Arlt, Susanne Sebens, Heiner Schäfer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 122 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 2%
Russia 1 <1%
Netherlands 1 <1%
Unknown 118 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 34 28%
Researcher 19 16%
Student > Master 13 11%
Student > Bachelor 12 10%
Student > Postgraduate 6 5%
Other 17 14%
Unknown 21 17%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 25 20%
Agricultural and Biological Sciences 25 20%
Medicine and Dentistry 24 20%
Pharmacology, Toxicology and Pharmaceutical Science 9 7%
Chemistry 4 3%
Other 12 10%
Unknown 23 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2022.
All research outputs
#5,344,962
of 25,394,764 outputs
Outputs from OncoTargets and therapy
#266
of 3,016 outputs
Outputs of similar age
#48,914
of 240,275 outputs
Outputs of similar age from OncoTargets and therapy
#3
of 22 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,275 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.